世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035230

皮膚科CRO市場-規模、シェア、動向分析レポート、予測2023-2030

Grand View Research Inc.

Dermatology CRO Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2023 - 2030

発刊日 2023/06

言語英語

体裁PDF/175ページ

ライセンス/価格175ページ

0000035230

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

皮膚科CRO市場の規模、シェア、動向分析レポート:種類別(前臨床、臨床)、サービスの種類別(検査機関、規制/医療事務)、地域別(北米、アジア太平洋)、およびセグメント予測、2023〜2030

レポートの概要
世界の皮膚科 CRO市場の規模は 2022 年に 47 億 3,770 万ドルと評価され、2023 年から 2030 年までに6.8%のCAGRで成長すると予想されます。円形脱毛症、アトピー性皮膚炎、座瘡などのさまざまな皮膚科疾患の負担が高く、研究需要を喚起していることが、市場の成長を牽引する主な要因の1つです。さらに、皮膚科メーカーがマーケティングや販売などの中核事業に注力することに関心が高まっていることから、皮膚科受託研究機関(CRO)が注目を集めており、これが市場の成長にさらなる貢献をしています。世界中でかなりの数の人々がさまざまな皮膚疾患を抱えています。

レポート詳細

目次

Table of Content

Chapter 1. Research Methodology And Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.1.2. Type
1.1.3. Service Type
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Dermatology CRO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing adoption of advanced technologies
3.2.1.2. Growing interest to look more appealing
3.2.1.3. Increasing outsourcing of R&D activities
3.2.1.4. Favorable environment for clinical trials in developing countries
3.2.2. Market Restraint Analysis
3.2.2.1. Quality issues of CRO services
3.2.2.2. Intellectual property rights issues
3.3. Dermatology CRO Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis

Chapter 4. Dermatology CRO Market: Type Estimates & Trend Analysis
4.1. Dermatology CRO Market, By Type: Segment Dashboard
4.2. Dermatology CRO Market, By Type: Movement Analysis
4.3. Dermatology CRO Market Estimates & Forecasts, By Type, 2018 - 2030
4.3.1. Drug Discovery
4.3.1.1. Drug Discovery Market, 2018 to 2030 (USD Million)
4.3.1.2. Target Validation
4.3.1.2.1. Target Validation Market, 2018 to 2030 (USD Million)
4.3.1.3. Lead Identification
4.3.1.3.1. Lead Identification Market, 2018 to 2030 (USD Million)
4.3.1.4. Lead Optimization
4.3.1.4.1. Lead Optimization Market, 2018 to 2030 (USD Million)
4.3.2. Preclinical
4.3.2.1. Preclinical Market, 2018 to 2030 (USD Million)
4.3.3. Clinical
4.3.3.1. Clinical Market, 2018 to 2030 (USD Million)
4.3.3.2. Phase I
4.3.3.2.1. Phase I Market, 2018 to 2030 (USD Million)
4.3.3.3. Phase II
4.3.3.3.1. Phase II Market, 2018 to 2030 (USD Million)
4.3.3.4. Phase III
4.3.3.4.1. Phase III Market, 2018 to 2030 (USD Million)
4.3.3.5. Phase IV
4.3.3.5.1. Phase IV Market, 2018 to 2030 (USD Million)

Chapter 5. Dermatology CRO Market: Service Type Estimates & Trend Analysis
5.1. Dermatology CRO Market, By Service Type: Segment Dashboard
5.2. Dermatology CRO Market, By Service Type: Movement Analysis
5.3. Dermatology CRO Market Estimates & Forecasts, By Service Type, 2018 - 2030
5.3.1. Project Management/Clinical Supply Management
5.3.1.1. Project Management/Clinical Supply Management Market, 2018 to 2030 (USD Million)
5.3.2. Data Management
5.3.2.1. Data Management Market, 2018 to 2030 (USD Million)
5.3.3. Regulatory/Medical Affairs
5.3.3.1. Regulatory/Medical Affairs Market, 2018 to 2030 (USD Million)
5.3.4. Medical Writing
5.3.4.1. Medical Writing Market, 2018 to 2030 (USD Million)
5.3.5. Clinical Monitoring
5.3.5.1. Clinical Monitoring Market, 2018 to 2030 (USD Million)
5.3.6. Quality Management/ Assurance
5.3.6.1. Quality Management/ Assurance Market, 2018 to 2030 (USD Million)
5.3.7. Bio-statistics
5.3.7.1. Bio-statistics Market, 2018 to 2030 (USD Million)
5.3.8. Investigator Payments
5.3.8.1. Investigator Payments Market, 2018 to 2030 (USD Million)
5.3.9. Laboratory
5.3.9.1. Laboratory Market, 2018 to 2030 (USD Million)
5.3.10. Patient and site Recruitment
5.3.10.1. Patient and site Recruitment Market, 2018 to 2030 (USD Million)
5.3.11. Laboratory
5.3.11.1. Laboratory Market, 2018 to 2030 (USD Million)
5.3.12. Technology
5.3.12.1. Technology Market, 2018 to 2030 (USD Million)
5.3.13. Others
5.3.13.1. Others Market, 2018 to 2030 (USD Million)

Chapter 6. Dermatology CRO Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2022 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. North America
6.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
6.5. Europe
6.5.1. UK
6.5.1.1. Key Country Dynamics
6.5.1.2. Competitive Scenario
6.5.1.3. Regulatory Framework
6.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
6.5.2. Germany
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
6.5.3. France
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
6.5.4. Italy
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
6.5.5. Spain
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
6.5.6. Denmark
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Denmark Market Estimates and Forecasts, 2018 - 2030
6.5.7. Sweden
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
6.5.8. Norway
6.5.8.1. Key Country Dynamics
6.5.8.2. Competitive Scenario
6.5.8.3. Regulatory Framework
6.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
6.6. Asia Pacific
6.6.1. Japan
6.6.1.1. Key Country Dynamics
6.6.1.2. Competitive Scenario
6.6.1.3. Regulatory Framework
6.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
6.6.2. India
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
6.6.4. South Korea
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
6.6.6. Thailand
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
6.7. Latin America
6.7.1. Brazil
6.7.1.1. Key Country Dynamics
6.7.1.2. Competitive Scenario
6.7.1.3. Regulatory Framework
6.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
6.7.2. Mexico
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
6.7.4. Colombia
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030
6.7.5. Chile
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030
6.8. MEA
6.8.1. South Africa
6.8.1.1. Key Country Dynamics
6.8.1.2. Competitive Scenario
6.8.1.3. Regulatory Framework
6.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
6.8.2. Saudi Arabia
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
6.8.3. UAE
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
6.8.4. Israel
6.8.4.1. Key Country Dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory Framework
6.8.4.4. Israel Market Estimates and Forecasts, 2018 - 2030
6.8.5. Iran
6.8.5.1. Key Country Dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory Framework
6.8.5.4. Iran Market Estimates and Forecasts, 2018 - 2030
6.8.6. Kuwait
6.8.6.1. Key Country Dynamics
6.8.6.2. Competitive Scenario
6.8.6.3. Regulatory Framework
6.8.6.4. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.1.1. Innovators
7.1.2. Market Leaders
7.1.3. Emerging Players
7.1.4. Company Market Share Analysis, 2022
7.2. Company Profiles
7.2.1. IQVIA, Inc.
7.2.1.1. Company Overview
7.2.1.2. Financial Performance
7.2.1.3. Service Benchmarking
7.2.1.4. Strategic Initiatives
7.2.2. Labcorp Drug Development
7.2.2.1. Company Overview
7.2.2.2. Financial Performance
7.2.2.3. Service Benchmarking
7.2.2.4. Strategic Initiatives
7.2.3. Aragen Life Sciences Ltd
7.2.3.1. Company Overview
7.2.3.2. Financial Performance
7.2.3.3. Service Benchmarking
7.2.3.4. Strategic Initiatives
7.2.4. Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
7.2.4.1. Company Overview
7.2.4.2. Financial Performance
7.2.4.3. Service Benchmarking
7.2.4.4. Strategic Initiatives
7.2.5. Parexel International Corporation
7.2.5.1. Company Overview
7.2.5.2. Financial Performance
7.2.5.3. Service Benchmarking
7.2.5.4. Strategic Initiatives
7.2.6. Charles River Laboratories
7.2.6.1. Company Overview
7.2.6.2. Financial Performance
7.2.6.3. Service Benchmarking
7.2.6.4. Strategic Initiatives
7.2.7. Icon, Plc
7.2.7.1. Company Overview
7.2.7.2. Financial Performance
7.2.7.3. Service Benchmarking
7.2.7.4. Strategic Initiatives
7.2.8. Medidata
7.2.8.1. Company Overview
7.2.8.2. Financial Performance
7.2.8.3. Service Benchmarking
7.2.8.4. Strategic Initiatives.
7.2.9. Syneos Health
7.2.9.1. Company Overview
7.2.9.2. Financial Performance
7.2.9.3. Service Benchmarking
7.2.9.4. Strategic Initiatives
7.2.10. S Pharmaron
7.2.10.1. Company Overview
7.2.10.2. Financial Performance
7.2.10.3. Service Benchmarking
7.2.10.4. Strategic Initiatives
7.2.11. Wuxi Apptec
7.2.11.1. Company Overview
7.2.11.2. Financial Performance
7.2.11.3. Service Benchmarking
7.2.11.4. Strategic Initiatives
7.2.12. Medpace
7.2.12.1. Company Overview
7.2.12.2. Financial Performance
7.2.12.3. Service Benchmarking
7.2.12.4. Strategic Initiatives
7.2.12.5. CTI Clinical Trial & Consulting
7.2.13. CTI Clinical Trial & Consulting
7.2.13.1. Company Overview
7.2.13.2. Financial Performance
7.2.13.3. Service Benchmarking
7.2.13.4. Strategic Initiatives
7.2.14. Bioskin
7.2.14.1. Company Overview
7.2.14.2. Financial Performance
7.2.14.3. Service Benchmarking
7.2.14.4. Strategic Initiatives
7.2.15. Proinnovera GmbH
7.2.15.1. Company Overview
7.2.15.2. Financial Performance
7.2.15.3. Service Benchmarking
7.2.15.4. Strategic Initiatives
7.2.16. Biorasi, LLC
7.2.16.1. Company Overview
7.2.16.2. Financial Performance
7.2.16.3. Service Benchmarking
7.2.16.4. Strategic Initiatives
7.2.17. Javara
7.2.17.1. Company Overview
7.2.17.2. Financial Performance
7.2.17.3. Service Benchmarking
7.2.17.4. Strategic Initiatives
7.2.18. TFS
7.2.18.1. Company Overview
7.2.18.2. Financial Performance
7.2.18.3. Service Benchmarking
7.2.18.4. Strategic Initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 North America Dermatology CRO Market, By Region, 2018 - 2030 (USD Million)
Table 4 North America Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 5 North America Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 6 U.S. Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 7 U.S. Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 8 Canada Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 9 Canada Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 10 Europe Dermatology CRO Market, By Region, 2018 - 2030 (USD Million)
Table 11 Europe Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 12 Europe Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 13 UK Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 14 UK Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 15 Germany Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 16 Germany Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 17 France Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 18 France Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 19 Italy Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 20 Italy Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 21 Spain Dermatology CRO Market, By Test Type, 2018 - 2030 (USD Million)
Table 22 Spain Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 23 Denmark Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 24 Denmark Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 25 Sweden Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 26 Sweden Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 27 Norway Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 28 Norway Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 29 Asia Pacific Dermatology CRO Market, By Region, 2018 - 2030 (USD Million)
Table 30 Asia Pacific Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 31 Asia Pacific Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 32 China Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 33 China Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 34 Japan Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 35 Japan Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 36 India Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 37 India Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 38 Australia Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 39 Australia Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 40 South Korea Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 41 South Korea Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 42 Thailand Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 43 Thailand Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 44 Latin America Dermatology CRO Market, By Region, 2018 - 2030 (USD Million)
Table 45 Latin America Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 46 Latin America Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 47 Brazil Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 48 Brazil Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 49 Mexico Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 50 Mexico Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 51 Argentina Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 52 Argentina Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 53 Colombia Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 54 Colombia Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 55 Chile Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 56 Chile Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 57 Middle East And Africa Dermatology CRO Market, By Region, 2018 - 2030 (USD Million)
Table 58 Middle East And Africa Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 59 Middle East And Africa Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 60 South Africa Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 61 South Africa Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 63 Saudi Arabia Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 64 UAE Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 65 UAE Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 66 Iran Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 67 Iran Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
Table 68 Israel Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
Table 69 Israel Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market segmentation & scope
Fig. 8 Dermatology CRO market outlook, 2018 - 2030
Fig. 9 Market trends & outlook
Fig. 10 Penetration & growth prospect mapping by service, 2022
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 SWOT Analysis, By factor (political & legal, economic and technological)
Fig. 14 Porter’s five forces analysis
Fig. 16 Global dermatology CRO market: Type movement analysis
Fig. 17 Drug discovery market 2018 - 2030 (USD Million)
Fig. 18 Target validation market 2018 - 2030 (USD Million)
Fig. 19 Lead identification market 2018 - 2030 (USD Million)
Fig. 20 Lead optimization market 2018 - 2030 (USD Million)
Fig. 21 Preclinical market 2018 - 2030 (USD Million)
Fig. 22 Clinical market 2018 - 2030 (USD Million)
Fig. 23 Phase I market 2018 - 2030 (USD Million)
Fig. 24 Phase II market 2018 - 2030 (USD Million)
Fig. 25 Phase III market 2018 - 2030 (USD Million)
Fig. 26 Phase IV market 2018 - 2030 (USD Million)
Fig. 27 Global dermatology CRO market: Service Type movement analysis
Fig. 28 Project management/clinical supply management market 2018 - 2030 (USD Million)
Fig. 29 Data management market 2018 - 2030 (USD Million)
Fig. 30 Regulatory/medical affairs market 2018 - 2030 (USD Million)
Fig. 31 Medical writing market 2018 - 2030 (USD Million)
Fig. 32 Clinical monitoring market 2018 - 2030 (USD Million)
Fig. 33 Quality management/ assurance market 2018 - 2030 (USD Million)
Fig. 34 Bio-statistics market 2018 - 2030 (USD Million)
Fig. 35 Investigator payments market 2018 - 2030 (USD Million)
Fig. 36 Laboratory market 2018 - 2030 (USD Million)
Fig. 37 Patient and site recruitment market 2018 - 2030 (USD Million)
Fig. 38 Technology market 2018 - 2030 (USD Million)
Fig. 39 Others market 2018 - 2030 (USD Million)
Fig. 40 Regional market place: Key takeaway
Fig. 41 Dermatology CRO regional outlook, 2022 & 2030
Fig. 42 North America dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 43 U.S. dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 44 Canada dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 45 Europe dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 46 Germany dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 47 France dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 48 UK dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 49 Spain dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 50 Italy dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 51 Sweden dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 52 Denmark dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 53 Norway dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 54 Asia Pacific dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 55 China dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 56 Japan dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 57 India dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 58 Australia dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 59 South Korea dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 59 Thailand dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 60 Latin America dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 61 Brazil dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 62 Mexico dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 63 Argentina dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 64 Colombia dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 65 Chile dermatology CRO market, 2018 - 2030 (USD Million)
Fig. 66 Middle East & Africa Dermatology CRO Market, 2018 - 2030 (USD Million)
Fig. 67 South Africa Dermatology CRO Market, 2018 - 2030 (USD Million)
Fig. 68 Saudi Arabia Dermatology CRO Market, 2018 - 2030 (USD Million)
Fig. 69 UAE Dermatology CRO Market, 2018 - 2030 (USD Million)
Fig. 70 Israel Arabia Dermatology CRO Market, 2018 - 2030 (USD Million)
Fig. 71 Iran Dermatology CRO Market, 2018 - 2030 (USD Million)
Fig. 72 Kuwait Dermatology CRO Market, 2018 - 2030 (USD Million)

この商品のレポートナンバー

0000035230

TOP